ERASURE: early autologous blood pleurodesis for postoperative air leaks—a randomized, controlled trial comparing prophylactic autologous blood pleurodesis versus standard watch and wait treatment for postoperative air leaks following thoracoscopic anatomic lung resections

Ioannis Karampinis,Christian Ruckes,Fabian Doerr,Servet Bölükbas,Sara Ricciardi,Giuseppe Cardillo,Carlos Galvez,Bogdan Vidmar,Tomaz Stupnik,Vincent Fang,Rene Horsleben Petersen,Eric Dominic Roessner
DOI: https://doi.org/10.1186/s13063-023-07875-z
IF: 2.728
2024-01-05
Trials
Abstract:The prolonged air leak is probably the most common complication following lung resections. Around 10–20% of the patients who undergo a lung resection will eventually develop a prolonged air leak. The definition of a prolonged air leak varies between an air leak, which is evident after the fifth, seventh or even tenth postoperative day to every air leak that prolongs the hospital stay. However, the postoperative hospital stay following a thoracoscopic lobectomy can be as short as 2 days, making the above definitions sound outdated. The treatment of these air leaks is also very versatile. One of the broadly accepted treatment options is the autologous blood pleurodesis or "blood patch". The purpose of this trial is to investigate the impact of a prophylactic autologous blood pleurodesis on reducing the duration of the postoperative air leak and therefore prevent the air leak from becoming prolonged.
medicine, research & experimental
What problem does this paper attempt to address?